Evidence map›Paper›PMID 28169594›Full record

ArticleTissue engineering. Part A2017

Keratin Hydrogel Enhances In Vivo Skeletal Muscle Function in a Rat Model of Volumetric Muscle Loss.

J A Passipieri, H B Baker, Mevan Siriwardane, Mary D Ellenburg, Manasi Vadhavkar, Justin M Saul, Seth Tomblyn, Luke Burnett, George J Christ

Open access · greenAbstract read
In one paragraph

Article in Tissue engineering. Part A, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 97 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. 3D bioprintable MgTheranostics · 2025
    Article
  8. Review
  9. Article
  10. Article
  11. Combined regenerative rehabilitation improves recovery following volumetric muscle loss injury in a rat model.Journal of biomedical materials research. Part B, Applied biomaterials · 2024
    Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

J A Passipieri1 Biomedical Engineering Department, University of Virginia , Charlottesville, Virginia.
H B Baker2 Wake Forest Institute for Regenerative Medicine, Wake Forest University , Winston-Salem, North Carolina.
Mevan Siriwardane2 Wake Forest Institute for Regenerative Medicine, Wake Forest University , Winston-Salem, North Carolina.
Mary D Ellenburg4 KeraNetics, LLC , Winston-Salem, North Carolina.
Manasi Vadhavkar2 Wake Forest Institute for Regenerative Medicine, Wake Forest University , Winston-Salem, North Carolina.
Justin M Saul5 Department of Chemical, Paper and Biomedical Engineering, Miami University , Oxford, Ohio.
Seth Tomblyn4 KeraNetics, LLC , Winston-Salem, North Carolina.
Luke Burnett4 KeraNetics, LLC , Winston-Salem, North Carolina.
George J Christ1 Biomedical Engineering Department, University of Virginia , Charlottesville, Virginia.
Forest Institute · USKeraNetics (United States) · USMiami University · USUniversity of Maryland, College Park · USWake Forest University · US

Funding

Studies in Translational Regenerative MedicineT32EB014836 · NIBIB · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI ANTHONY ATALA, Victoria Weis · 2013 to 2026
$1.7M
NIBIB NIH HHS T32 EB014836
6 · The paper itself

Abstract

Volumetric muscle loss (VML) injuries exceed the considerable intrinsic regenerative capacity of skeletal muscle, resulting in permanent functional and cosmetic deficits. VML and VML-like injuries occur in military and civilian populations, due to trauma and surgery as well as due to a host of congenital and acquired diseases/syndromes. Current therapeutic options are limited, and new approaches are needed for a more complete functional regeneration of muscle. A potential solution is human hair-derived keratin (KN) biomaterials that may have significant potential for regenerative therapy. The goal of these studies was to evaluate the utility of keratin hydrogel formulations as a cell and/or growth factor delivery vehicle for functional muscle regeneration in a surgically created VML injury in the rat tibialis anterior (TA) muscle. VML injuries were treated with KN hydrogels in the absence and presence of skeletal muscle progenitor cells (MPCs), and/or insulin-like growth factor 1 (IGF-1), and/or basic fibroblast growth factor (bFGF). Controls included VML injuries with no repair (NR), and implantation of bladder acellular matrix (BAM, without cells). Initial studies conducted 8 weeks post-VML injury indicated that application of keratin hydrogels with growth factors (KN, KN+IGF-1, KN+bFGF, and KN+IGF-1+bFGF, n = 8 each) enabled a significantly greater functional recovery than NR (n = 7), BAM (n = 8), or the addition of MPCs to the keratin hydrogel (KN+MPC, KN+MPC+IGF-1, KN+MPC+bFGF, and KN+MPC+IGF-1+bFGF, n = 8 each) (p < 0.05). A second series of studies examined functional recovery for as many as 12 weeks post-VML injury after application of keratin hydrogels in the absence of cells. A significant time-dependent increase in functional recovery of the KN, KN+bFGF, and KN+IGF+bFGF groups was observed, relative to NR and BAM implantation, achieving as much as 90% of the maximum possible functional recovery. Histological findings from harvested tissue at 12 weeks post-VML injury documented significant increases in neo-muscle tissue formation in all keratin treatment groups as well as diminished fibrosis, in comparison to both BAM and NR. In conclusion, keratin hydrogel implantation promoted statistically significant and physiologically relevant improvements in functional outcomes post-VML injury to the rodent TA muscle.

Indexed as

HydrogelsKeratinsMuscle, SkeletalAnimalsFibroblast Growth Factor 2Insulin-Like Growth Factor IMaleRatsRats, Inbred LewRegenerationFibroblast Growth Factor 2Hydrogelsinsulin-like growth factor-1, ratInsulin-Like Growth Factor IKeratinsFGFfunctional recoveryIGFkeratinmyogenesisvolumetric muscle loss

Identifiers

PMID28169594
PMCPMC6916122
OpenAlexW2610293228

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.